An Exercise Facilitator to Activate Simple Training Programs in the Dialysis CenterLast updated on July 2021
- Recruitment Status
- Estimated Enrollment
- Same as current
- Chronic Kidney Disease Stage 5 on Dialysis
- Not Applicable
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: End-stage kidney disease patients will be proposed to choose between one of the three organizational models of exercise (counselling; home-based prescription; supervised) or to take part in the project as a control group (no exercise).Masking: Single (Outcomes Assessor)Masking Description: Outcome measures assessors will be blinded to group allocationPrimary Purpose: Treatment
- Between 18 years and 125 years
- Both males and females
The assumption underlying the project is that a wider participation to physical activity programs (PAPs) of ESKD patients may be facilitated by the presence in the Renal Unit of an exercise specialist able to design tailored programs and that this intervention may lead to measurable benefits on phys...
The assumption underlying the project is that a wider participation to physical activity programs (PAPs) of ESKD patients may be facilitated by the presence in the Renal Unit of an exercise specialist able to design tailored programs and that this intervention may lead to measurable benefits on physical fitness, quality of life and general health. The possible different solutions offered by an expert of exercise in chronic diseases might reduce most of the barriers to exercise responsible of the sedentary behavior of the ESKD patients. Aim of the project is to test the impact of the regular presence of this facilitator in a Nephrology Unit in terms of applicability and feasibility as well to identify the preferred and the most effective pathways for the patients. The identification of a novel cost-effective intervention may represent an important step to manage the change of lifestyle of ESKD patients, to slow down their physical and QoL decline and to reduce hospitalizations and negative outcomes affecting this population.
- NCT #
- Università degli Studi di Ferrara
- Principal Investigator: Fabio Manfredini, MD University of Ferrara and University Hospital of Ferrara Principal Investigator: Alda Storari, MD University Hospital of Ferrara